---
$id: https://graph.org.ai/products/commodity/51372109
$type: Product
source: UNSPSC
code: "51372109"
title: "Oxymorphone"
class: "51372100"
classTitle: "Controlled substance analgesic morphine derivatives"
family: "51370000"
familyTitle: "Controlled substance analgesics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Oxymorphone

**UNSPSC Code**: 51372109
**Class**: [Controlled substance analgesic morphine derivatives](Controlled substance analgesic morphine derivatives.mdx)
**Family**: [Controlled substance analgesics](../Controlled substance analgesics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an opioid receptor agonist and opioid with the molecular formula C17H19NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9VXA968E0C, chemically known as 3,14-dihydroxy-4,5-alpha-epoxy-17-methylmorphinan-6-one but generally known as oxymorphone, which bears US NIH Compound Identifier 5284604. European Medicines Agency schedules Oxymorphone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09569MIG. The term OXYMORPHONE is an International Non-Proprietary Name. OXYMORPHONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule oxymorphone under HS 29391100 and SITC 54141. As of Q4 2014, OXYMORPHONE remains the US FDA Preferred Term for this commodity. Oxymorphone bears US NLM identifiers UMLS ID C0030073 and NCI Concept Code C29314. SMILES: O1C2C34C(O)(C(N(CC3)C)CC3C4C1C(O)CC3)CCC2=O.

